Related Experiment Video
Updated: Apr 14, 2026

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Fueling asthma inflammation via bioenergetic metabolic reprogramming
Anny Mulya1, Allison J Janocha1, Michael V Novotny1
1Department of Inflammation and Immunity , Cleveland Clinic Research, Cleveland, OH, USA.
Asthma involves metabolic changes, with altered bioenergetic networks and increased lipid metabolism pathways. This study reveals a unique bioenergetic phenotype in asthma patients, impacting cellular energy production and utilization.
Area of Science:
- Biochemistry
- Systems Biology
- Metabolomics
Background:
- Metabolic and bioenergetic abnormalities are linked to asthma.
- The precise mechanisms connecting these disruptions to asthma pathophysiology are not fully understood.
Purpose of the Study:
- To investigate the hypothesis that asthma arises from altered connectivity within metabolic networks.
- To map the bioenergetic-metabolite interactome in asthma using a systems-level approach.
Main Methods:
- Integrated platelet bioenergetic profiling and plasma metabolomics.
- Analyzed fasting plasma metabolites and platelet bioenergetics in individuals with asthma (n=40) and healthy controls (n=18).
- Studied primary human airway smooth muscle cells.
Main Results:
- Identified 119 altered metabolites, with adenosine derivatives correlating with inflammation and lung function.
- Observed reduced ATP-linked oxygen consumption and greater bioenergetic reserve capacity in asthma.
- Found decreased mitochondrial glucose utilization in asthma airway smooth muscle cells.
- Revealed a restructured metabolic network in asthma with fewer connections and new clusters enriched in lipid metabolism.
Conclusions:
- Asthma exhibits a distinct bioenergetic phenotype characterized by increased oxidative reserve capacity.
- Reduced mitochondrial glucose utilization and a shift towards lipid metabolism pathways are key features of asthma.
- The study highlights a restructured bioenergetic-metabolite network in asthma, offering new insights into disease mechanisms.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

